Savant Capital’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.14M | Sell |
18,722
-662
| -3% | -$183K | 0.01% | 443 |
|
|
2026
Q1 | $5.72M | Buy |
19,384
+992
| +5% | +$295K | 0.03% | 247 |
|
|
2025
Q4 | $5.02M | Sell |
18,392
-35
| -0.2% | -$9.51K | 0.03% | 251 |
|
|
2025
Q3 | $4.98M | Buy |
18,427
+168
| +0.9% | +$45.7K | 0.03% | 238 |
|
|
2025
Q2 | $5.03M | Buy |
18,259
+763
| +4% | +$207K | 0.04% | 211 |
|
|
2025
Q1 | $4.64M | Sell |
17,496
-31,326
| -64% | -$7.73M | 0.04% | 204 |
|
|
2024
Q4 | $11.3M | Buy |
48,822
+15,704
| +47% | +$3.61M | 0.09% | 145 |
|
|
2024
Q3 | $7.31M | Sell |
33,118
-4,576
| -12% | -$947K | 0.06% | 175 |
|
|
2024
Q2 | $7.41M | Sell |
37,694
-6,674
| -15% | -$1.38M | 0.07% | 161 |
|
|
2024
Q1 | $9.55M | Sell |
44,368
-2,754
| -6% | -$579K | 0.11% | 130 |
|
|
2023
Q4 | $9.92M | Buy |
47,122
+1,059
| +2% | +$226K | 0.13% | 118 |
|
|
2023
Q3 | $9.22M | Sell |
46,063
-1,882
| -4% | -$374K | 0.14% | 120 |
|
|
2023
Q2 | $8.88M | Buy |
47,945
+110
| +0.2% | +$20.3K | 0.14% | 117 |
|
|
2023
Q1 | $9.16M | Buy |
47,835
+264
| +0.6% | +$47.7K | 0.17% | 92 |
|
|
2022
Q4 | $8M | Sell |
47,571
-5,891
| -11% | -$1.02M | 0.2% | 66 |
|
|
2022
Q3 | $9.47M | Sell |
53,462
-423
| -0.8% | -$83.6K | 0.3% | 51 |
|
|
2022
Q2 | $11M | Sell |
53,885
-401
| -0.7% | -$85K | 0.33% | 47 |
|
|
2022
Q1 | $12.9M | Sell |
54,286
-147
| -0.3% | -$34.5K | 0.42% | 43 |
|
|
2021
Q4 | $12.4M | Sell |
54,433
-1,583
| -3% | -$348K | 0.4% | 42 |
|
|
2021
Q3 | $10.8M | Buy |
56,016
+285
| +0.5% | +$57.7K | 0.4% | 39 |
|
|
2021
Q2 | $11.9M | Sell |
55,731
-226
| -0.4% | -$47.7K | 0.48% | 35 |
|
|
2021
Q1 | $11.4M | Sell |
55,957
-756
| -1% | -$149K | 0.61% | 30 |
|
|
2020
Q4 | $10.3M | Sell |
56,713
-2,064
| -4% | -$351K | 0.6% | 31 |
|
|
2020
Q3 | $9.83M | Buy |
58,777
+1,637
| +3% | +$276K | 0.67% | 31 |
|
|
2020
Q2 | $9.29M | Sell |
57,140
-5
| -0% | -$896 | 0.7% | 30 |
|
|
2020
Q1 | $9.88M | Sell |
57,145
-2,041
| -3% | -$406K | 0.94% | 22 |
|
|
2019
Q4 | $11.9M | Sell |
59,186
-506
| -0.8% | -$104K | 1.46% | 10 |
|
|
2019
Q3 | $12.6M | Sell |
59,692
-153
| -0.3% | -$32K | 1.75% | 8 |
|
|
2019
Q2 | $11.6M | Sell |
59,845
-117
| -0.2% | -$21.6K | 1.64% | 10 |
|
|
2019
Q1 | $9.87M | Sell |
59,962
-1,251
| -2% | -$221K | 1.85% | 8 |
|
|
2018
Q4 | $11.5M | Sell |
61,213
-229
| -0.4% | -$42.3K | 2.41% | 5 |
|
|
2018
Q3 | $10.5M | Sell |
61,442
-8,212
| -12% | -$1.38M | 1.88% | 10 |
|
|
2018
Q2 | $11.4M | Buy |
69,654
+90
| +0.1% | +$14.7K | 2.44% | 4 |
|
|
2018
Q1 | $11.3M | Sell |
69,564
-1,164
| -2% | -$185K | 2.37% | 4 |
|
|
2017
Q4 | $10.3M | Sell |
70,728
-100
| -0.1% | -$14.2K | 2.17% | 7 |
|
|
2017
Q3 | $9.61M | Hold |
70,828
| – | – | 2.16% | 7 |
|
|
2017
Q2 | $8.87M | Sell |
70,828
-250
| -0.4% | -$29.9K | 2.1% | 7 |
|
|
2017
Q1 | $8.44M | Sell |
71,078
-847
| -1% | -$102K | 2.09% | 8 |
|
|
2016
Q4 | $8.3M | Sell |
71,925
-135
| -0.2% | -$15K | 2.23% | 8 |
|
|
2016
Q3 | $7.53M | Sell |
72,060
-18,000
| -20% | -$1.88M | 2.07% | 8 |
|
|
2016
Q2 | $8.77M | Sell |
90,060
-12,020
| -12% | -$1.14M | 2.51% | 8 |
|
|
2016
Q1 | $9.8M | Buy |
102,080
+220
| +0.2% | +$20K | 2.98% | 8 |
|
|
2015
Q4 | $9.23M | Sell |
101,860
-120
| -0.1% | -$11.3K | 2.88% | 8 |
|
|
2015
Q3 | $9.46M | Hold |
101,980
| – | – | 3.39% | 7 |
|
|
2015
Q2 | $9.49M | Buy |
101,980
+99,850
| +4,688% | +$9.32M | 3.19% | 7 |
|
|
2015
Q1 | $202K | Buy |
+2,130
| New | +$197K | 0.07% | 205 |
|
Other funds holding CME
Savant Capital's CME Position: Q2 2026 in Review
Savant Capital reduced its CME Group (CME) stake by 3.4% in Q2 2026, selling an estimated $183K and leaving 18,722 shares worth $4.14M. The position accounts for 0.01% of the portfolio, ranked #443.
Savant Capital first reported a position in CME in Q1 2015 and has held it in 46 quarters since. The position peaked at $12.9M in Q1 2022. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Savant Capital held 18,722 shares of CME Group worth $4.14M as of Q2 2026.
- Savant Capital sold 662 CME Group shares in Q2 2026, an estimated $183K.
- CME Group made up 0.01% of Savant Capital's portfolio in Q2 2026, its #443 holding.
- Savant Capital first reported a position in CME Group in Q1 2015 and has held it in 46 quarters since.
- Savant Capital's CME Group position peaked at $12.9M in Q1 2022.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.